Old Web
English
Sign In
Acemap
>
authorDetail
>
H. Gallowitsch
H. Gallowitsch
Medicine
Radiology
Sorafenib
Thyroid cancer
Refractory
4
Papers
9
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria
2020
International Journal of Endocrinology
G. Rendl
B Sipos
A. Becherer
S. Sorko
C. Trummer
M. Raderer
Wolfgang Hitzl
M. Ardelt
H. Gallowitsch
C. Pirich
Show All
Source
Cite
Save
Citations (5)
Therapie des Patienten mit Radioiod-refraktärem, differenziertem Schilddrüsenkarzinom : Ein Konsensusstatement
2015
J. Dierneder
G. Pall
Christian Pirich
Martha Hoffmann
M. Raderer
Alexander Becherer
Bruno Niederle
R. Lipp
P. Lind
H. Gallowitsch
F. Romeder
Irene Virgolini
C. Lindner
Show All
Source
Cite
Save
Citations (1)
Therapie des Patienten mit Radioiod-refraktärem, differenziertem Schilddrüsenkarzinom
2015
Nuklearmedizin-nuclear Medicine
C. Lindner
J. Dierneder
G. Pall
Christian Pirich
Martha Hoffmann
M. Raderer
Alexander Becherer
Bruno Niederle
R. Lipp
P. Lind
H. Gallowitsch
F. Romeder
Irene Virgolini
Show All
Source
Cite
Save
Citations (1)
[Treatment of patients with radioiodine refractory, differentiated thyroid carcinoma. A Consensus Statement].
2015
Nuklearmedizin-nuclear Medicine
Christina Lindner
J. Dierneder
G. Pall
Christian Pirich
Martha Hoffmann
Markus Raderer
Alexander Becherer
Bruno Niederle
R. Lipp
P. Lind
H. Gallowitsch
F. Romeder
Irene Virgolini
Show All
Source
Cite
Save
Citations (2)
1
map